NeoStem announces geographic expansion of IP coverage of AMR-001

NeoStem announced the geographic expansion of intellectual property protection around its lead product candidate, AMR-001, with the notice of patent grant in Malaysia and notice of recommendation for patent allowance in the Philippines. These patents are in the family of U.S. patent number 7,794,705 titled "Compositions and Methods of Vascular Injury Repair" and protect a chemotactic stem cell product enriched for CD34+ cells that treats injury from acute myocardial infarction. Additionally, NeoStem has been granted a second South African patent titled "Infarct Area Perfusion-Improving Compositions and Methods of Vascular Injury Repair."